The brain fog piece is the one that catches women off guard the most. Nobody warns you that dropping estrogen can make you feel like you're thinking through wet cement — and then someone suggests a mushroom and it sounds absurd. But when you dig into what lion's mane actually does at the cellular level, it stops sounding like wellness marketing and starts sounding like a reasonable experiment worth having.
Learn more about Rose →Lion's mane (Hericium erinaceus) contains two families of compounds — hericenones and erinacines — that cross the blood-brain barrier and stimulate the production of nerve growth factor (NGF). NGF is a protein the brain uses to maintain, repair, and grow neurons, particularly in the hippocampus, which is the region most involved in memory and learning. Estrogen normally supports NGF signaling, so when estrogen declines during perimenopause, NGF activity drops — making a supplement that nudges it back up mechanistically relevant rather than speculative.
One of the less-discussed consequences of falling estrogen is a rise in neuroinflammatory signaling in the brain. Estrogen acts as a natural anti-inflammatory agent in neural tissue, so its decline leaves the brain more vulnerable to low-grade inflammation that impairs cognitive speed and clarity. Preclinical research shows lion's mane extract reduces markers of neuroinflammation, including TNF-α and IL-6, which places it in a small category of supplements with a mechanism genuinely tied to what's happening hormonally.
A 2023 randomized controlled trial published in Neurological Sciences examined lion's mane supplementation in perimenopausal and menopausal women over 12 weeks and found significant improvements in scores for depression, anxiety, and concentration compared to placebo. The trial was small — 77 participants — which means it cannot be treated as definitive, but it is notable because most cognitive supplement research is done in older adults with diagnosed decline rather than in the specific hormonal context of menopause. This study is often cited as the starting point for evidence-grading lion's mane in this population.
NGF and its close relative BDNF (brain-derived neurotrophic factor) are both implicated in mood regulation, not just memory. Declining levels of these neurotrophins during perimenopause may contribute to the low mood, irritability, and anxiety many women experience — symptoms that sit uncomfortably between 'hormonal' and 'psychiatric' and often get mislabeled as depression. The same mechanisms by which lion's mane supports neuronal health may therefore benefit emotional regulation, a finding that has shown up in both the menopause-specific RCT and broader cognitive research.
Studies have used doses ranging from 250 mg to 3,000 mg per day, with most human trials clustering around 500–1,000 mg of a standardized extract. Critically, the bioactive compounds (hericenones and erinacines) are present in different concentrations depending on whether the product uses the fruiting body, the mycelium, or both, and whether it is a hot-water extract, an alcohol extract, or a dual extract. This makes comparing products genuinely difficult, and it is why dose guidance from a single study does not translate cleanly into supplement aisle choices.
Hormone replacement therapy remains the most evidence-supported intervention for cognitive symptoms driven by estrogen withdrawal, particularly when started within the first decade after menopause onset. Lion's mane does not restore estrogen, does not address vasomotor symptoms, and has not been studied against HRT as a comparator. What it may offer is a meaningful adjunct — something that supports the neurological environment independently — rather than an alternative for women who are avoiding hormones or delaying the decision.
Lion's mane has a long history of culinary and medicinal use in East Asian traditions, and clinical trials to date have not identified serious adverse effects at standard doses. The most commonly reported issues are mild gastrointestinal discomfort in some users. The one caveat worth noting is a documented potential for allergic reaction — including respiratory symptoms — in people with mushroom allergies or sensitivities, and there are rare case reports of contact dermatitis. Anyone with a history of mushroom allergy should approach with caution and ideally discuss with a clinician first.
Unlike caffeine or even some adaptogens that produce noticeable effects within hours, lion's mane works by gradually upregulating neurotrophic factors and reducing chronic neuroinflammation — processes that unfold over weeks of consistent use. The 2023 menopause RCT ran for 12 weeks before measuring outcomes, which aligns with what the mechanism would predict. Women trying lion's mane for cognitive symptoms should expect to commit to at least 8–12 weeks before making a fair assessment of whether it is doing anything useful for them.
The cognitive changes of perimenopause are multifactorial — driven by hormonal shifts, sleep disruption, cortisol dysregulation, and lifestyle factors simultaneously — which means no single supplement is going to carry the whole load. Lion's mane makes the most sense as part of a broader approach that also addresses sleep quality, blood sugar stability, stress load, and physical movement, all of which independently support brain health during this transition. Thinking of it as one well-chosen piece of a larger puzzle is both accurate to the evidence and a more realistic framework for what supplementation can actually deliver.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.